0,941  0,001  Aldose reductase substrate
0,941  0,005  Antiinflammatory
0,916  0,002  NOS3 expression inhibitor
0,883  0,005  Cyclophilin D inhibitor
0,883  0,005  Antidiabetic
0,885  0,007  Apoptosis agonist
0,849  0,003  Angiogenesis stimulant
0,837  0,004  Antioxidant
0,833  0,004  Cardioprotectant
0,806  0,010  Caspase 9 stimulant
0,786  0,004  5 Hydroxytryptamine release stimulant
0,783  0,002  NOS3 expression enhancer
0,768  0,002  Alpha-N-acetylglucosaminidase inhibitor
0,754  0,005  Nitric oxide antagonist
0,751  0,003  Hepatoprotectant
0,746  0,005  Immunomodulator
0,740  0,005  Hepatic disorders treatment
0,733  0,005  Free radical scavenger
0,735  0,012  Embryotoxic
0,719  0,004  Apoptosis antagonist
0,718  0,011  Antileukemic
0,712  0,015  Teratogen
0,699  0,010  Antihypercholesterolemic
0,692  0,005  AR expression inhibitor
0,691  0,005  Hypoglycemic
0,676  0,004  Antineoplastic (sarcoma)
0,677  0,006  Immunosuppressant
0,676  0,010  Mutagenic
0,673  0,010  Antithrombotic
0,661  0,004  Genotoxic
0,655  0,001  Alpha-mannosidase inhibitor
0,664  0,025  Transcription factor NF kappa B inhibitor
0,641  0,005  Vascular (periferal) disease treatment
0,632  0,001  Mannosidase inhibitor
0,630  0,005  Antihypoxic
0,636  0,025  Antiarthritic
0,630  0,026  Antineoplastic (lung cancer)
0,621  0,021  Antineoplastic (colorectal cancer)
0,603  0,006  Antineoplastic (osteosarcoma)
0,604  0,007  Tumour necrosis factor alpha release inhibitor
0,602  0,005  Skin whitener
0,590  0,005  Wound healing agent
0,590  0,005  Antihypertriglyceridemic
0,588  0,006  Antineoplastic (lymphoma)
0,599  0,019  Cholesterol antagonist
0,585  0,008  UDP-glucuronosyltransferase substrate
0,586  0,009  Antifungal
0,583  0,009  Antipyretic
0,581  0,013  Cytostatic
0,580  0,012  Caspase 3 stimulant
0,585  0,022  Antibacterial
0,563  0,002  NADH dehydrogenase inhibitor
0,565  0,005  ICAM1 expression inhibitor
0,568  0,013  NOS2 expression inhibitor
0,570  0,015  Antipruritic, allergic
0,565  0,019  Antineoplastic (ovarian cancer)
0,573  0,028  GST A substrate
0,560  0,015  Chemopreventive
0,548  0,005  Amylase inhibitor
0,556  0,014  Antiosteoporotic
0,555  0,014  Antipsoriatic
0,579  0,038  Antineoplastic (breast cancer)
0,546  0,010  DNA damaging
0,540  0,008  RNA-directed DNA polymerase inhibitor
0,551  0,023  Immunostimulant
0,540  0,014  Antidiabetic (type 2)
0,548  0,027  Antineoplastic (colon cancer)
0,553  0,034  TNF expression inhibitor
0,534  0,022  Bone diseases treatment
0,515  0,002  UDP-glucose 4-epimerase inhibitor
0,516  0,007  Antineoplastic (small cell lung cancer)
0,513  0,004  Carcinogenic, group 1
0,526  0,021  Cytotoxic
0,524  0,020  Radioprotector
0,510  0,008  Antineoplastic (liver cancer)
0,502  0,003  Selectin antagonist
0,530  0,031  CYP2C9 substrate
0,524  0,025  Respiratory analeptic
0,501  0,005  Antiviral (Influenza)
0,500  0,004  Dementia treatment
0,499  0,004  Vascular dementia treatment
0,499  0,005  Lipid peroxidase inhibitor
0,513  0,022  Antineoplastic (melanoma)
0,493  0,004  Cell adhesion inhibitor
0,506  0,019  UGT1A9 substrate
0,484  0,002  Nitric-oxide synthase stimulant
0,490  0,009  Anesthetic general
0,502  0,023  Carcinogenic
0,495  0,016  Antiparasitic
0,488  0,009  Interleukin 2 agonist
0,491  0,013  Vasodilator
0,480  0,003  Antineoplastic, alkylator
0,493  0,019  Proliferative diseases treatment
0,483  0,015  DNA synthesis inhibitor
0,484  0,024  Chemoprotective
0,482  0,023  Lipoprotein disorders treatment
0,463  0,009  Antiviral (Herpes)
0,467  0,016  UGT2B4 substrate
0,470  0,020  Vasodilator, coronary
0,445  0,005  Antipruritic, non-allergic
0,454  0,015  Antineoplastic enhancer
0,515  0,076  Alpha-glucosidase inhibitor
0,438  0,002  Transcription factor NF kappa B stimulant
0,445  0,013  Antiulcerative
0,446  0,014  Myocardial infarction treatment
0,466  0,036  Stroke treatment
0,435  0,009  Topoisomerase II inhibitor
0,430  0,005  Topoisomerase I inhibitor
0,428  0,008  GST M1-1 substrate
0,422  0,003  Mannose-6-phosphate isomerase inhibitor
0,425  0,005  Diabetic nephropathy treatment
0,421  0,004  Antihemorrhagic
0,447  0,031  Spasmolytic
0,432  0,020  Antidiabetic symptomatic
0,440  0,029  Antineoplastic (glioma)
0,422  0,011  Non-steroidal antiinflammatory agent
0,424  0,015  UGT1A1 substrate
0,438  0,031  Antiischemic
0,444  0,043  Prostate cancer treatment
0,404  0,007  Antiviral (Influenza A)
0,428  0,032  Analeptic
0,420  0,026  Antiprotozoal (Leishmania)
0,396  0,005  Antineoplastic antibiotic
0,397  0,008  Alkylator
0,395  0,008  Hemostatic
0,405  0,018  Interleukin agonist
0,393  0,007  Peptidyltransferase inhibitor
0,389  0,004  Triose-phosphate isomerase inhibitor
0,395  0,017  Antihelmintic
0,385  0,013  Platelet adhesion inhibitor
0,419  0,049  Vasodilator, peripheral
0,370  0,008  Antidiarrheal
0,368  0,009  Interleukin 6 antagonist
0,364  0,005  Expectorant
0,360  0,005  Hexokinase inhibitor
0,357  0,004  Carcinogenic, group 2A
0,353  0,001  Glucose-6-phosphate isomerase inhibitor
0,388  0,038  Antineoplastic (cervical cancer)
0,417  0,068  5 Hydroxytryptamine release inhibitor
0,390  0,042  Antineoplastic (brain cancer)
0,356  0,011  Protein kinase stimulant
0,368  0,030  UGT1A6 substrate
0,373  0,036  Calcium channel activator
0,398  0,063  CYP3A4 substrate
0,338  0,004  Antifungal (Cryptococcus)
0,368  0,038  Sensitization
0,330  0,004  Phosphofructokinase-1 inhibitor
0,412  0,088  Alzheimer's disease treatment
0,325  0,004  Histone deacetylase stimulant
0,325  0,004  Histone deacetylase SIRT1 stimulant
0,346  0,026  Abortion inducer
0,354  0,035  Antineoplastic (renal cancer)
0,343  0,024  Septic shock treatment
0,326  0,008  Antifungal enhancer
0,350  0,035  Hypolipemic
0,336  0,022  Antimutagenic
0,377  0,070  Ulceration
0,346  0,040  Antiamyloidogenic
0,317  0,011  Acute respiratory distress syndrome (ARDS) treatment
0,322  0,016  Phospholipase C inhibitor
0,320  0,021  Gastrin inhibitor
0,304  0,005  ATPase inhibitor
0,376  0,079  Antiprotozoal
0,306  0,014  Growth factor agonist
0,306  0,016  Neurotrophic factor enhancer
0,341  0,053  CYP2C19 substrate
0,290  0,002  Glycine receptor antagonist
0,308  0,021  Diuretic
0,348  0,063  FMO1 substrate
0,301  0,018  Monophenol monooxygenase inhibitor
0,365  0,083  CYP2C19 inhibitor
0,298  0,018  Sepsis treatment
0,291  0,013  Insulin secretagoues
0,280  0,005  AMP-activated protein kinase stimulant
0,321  0,046  Platelet antagonist
0,301  0,033  Antiviral (HIV)
0,275  0,009  Xanthine oxidase inhibitor
0,272  0,008  Anticataract
0,271  0,007  Beta amyloid protein antagonist
0,286  0,023  Carcinogenic, group 3
0,291  0,028  VCAM1 expression inhibitor
0,273  0,012  Cell wall synthesis inhibitor
0,279  0,020  Bone formation stimulant
0,356  0,097  Histamine release inhibitor
0,296  0,043  Cyclic AMP phosphodiesterase inhibitor
0,274  0,023  Antineoplastic (gastric cancer)
0,253  0,004  Glutamate release inhibitor
0,264  0,017  Glutathione S-transferase substrate
0,251  0,005  Chronic obstructive bronchitis treatment
0,269  0,025  Interferon gamma antagonist
0,252  0,008  Microtubule formation inhibitor
0,324  0,082  Angiogenesis inhibitor
0,279  0,038  Antihypotensive
0,267  0,027  Antiacne
0,249  0,009  Cyclooxygenase 3 inhibitor
0,243  0,005  Thioredoxin inhibitor
0,247  0,009  Antispirochetal
0,252  0,018  Aldehyde dehydrogenase inhibitor
0,269  0,035  UGT2B7 substrate
0,284  0,052  Antineoplastic (glioblastoma multiforme)
0,257  0,025  UGT2B15 substrate
0,236  0,005  Sphingomyelinase inhibitor
0,259  0,029  Acaricide
0,240  0,010  Antirickettsial
0,230  0,007  Antiviral (Influenza B)
0,255  0,032  Thrombolytic
0,231  0,010  CF transmembrane conductance regulator agonist
0,227  0,006  Mannitol-1-phosphate 5-dehydrogenase inhibitor
0,227  0,006  Adenylate cyclase stimulant
0,227  0,007  Hearing loss treatment
0,240  0,021  Renal failure treatment
0,321  0,103  Antiobesity
0,249  0,032  Antihelmintic (Nematodes)
0,218  0,004  Neuraminidase (influenza) inhibitor
0,287  0,074  Antineoplastic (pancreatic cancer)
0,225  0,013  Alcohol dehydrogenase substrate
0,223  0,013  Carbonic anhydrase III inhibitor
0,240  0,030  Melanin inhibitor
0,222  0,013  Antischistosomal
0,275  0,067  Radiosensitizer
0,230  0,023  GST P1-1 substrate
0,203  0,003  Ca2+-transporting ATPase inhibitor
0,233  0,034  Antineoplastic (squamous cell carcinoma)
0,213  0,014  UDP-N-acetylglucosamine 1-carboxyvinyltransferase inhibitor
0,282  0,083  Metabolic disease treatment
0,215  0,021  Antitussive
0,239  0,048  Glyceraldehyde-3-phosphate dehydrogenase inhibitor
0,212  0,023  Arachidonic acid antagonist
0,270  0,084  CYP1A2 substrate
0,201  0,017  Choleretic
0,187  0,004  Antiviral (Dengue virus)
0,210  0,030  UGT2B10 substrate
0,229  0,051  Pneumotoxic
0,192  0,018  Constipation treatment
0,190  0,016  Adenylate kinase inhibitor
0,180  0,010  Toll-Like receptor 4 antagonist
0,176  0,005  Phosphodiesterase 6D inhibitor
0,183  0,012  DNA repair enzyme inhibitor
0,185  0,015  Carbonic anhydrase VI inhibitor
0,178  0,009  GST T1-1 substrate
0,193  0,027  Adenylate cyclase inhibitor
0,200  0,034  Cyclooxygenase 1 inhibitor
0,242  0,077  Cardiovascular analeptic
0,169  0,004  ATPase (Vacuolar H+) inhibitor
0,179  0,015  Antibiotic
0,205  0,042  Muscular dystrophy treatment
0,172  0,009  Antidote, mercury
0,165  0,005  Antibiotic Glycopeptide-like
0,187  0,028  Cystathionine beta-synthase inhibitor
0,210  0,052  Antiviral (Hepatitis)
0,161  0,005  Neuraminidase inhibitor
0,176  0,020  Gastritis treatment
0,181  0,026  Carcinogenic, group 2B
0,172  0,017  Beta glucuronidase inhibitor
0,174  0,021  Mucolytic
0,184  0,032  Antiviral (Hepatitis B)
0,171  0,019  Topoisomerase II alpha inhibitor
0,151  0,001  Antibiotic Aminoglycoside-like
0,255  0,105  CTGF expression inhibitor
0,153  0,004  Antimycoplasmal
0,153  0,005  Na+ K+ transporting ATPase inhibitor
0,186  0,037  Skin irritative effect
0,191  0,044  Uterine stimulant
0,154  0,012  Antimetabolite
0,160  0,018  Actinic keratosis treatment
0,188  0,046  UGT2B9 substrate
0,153  0,011  Carbamoyl phosphate synthetase inhibitor
0,246  0,104  Hypoxia-inducible factor 1 alpha inhibitor
0,230  0,090  Tyrosine 3 hydroxylase inhibitor
0,224  0,084  Antineoplastic (lymphocytic leukemia)
0,151  0,012  Postmenopausal disorders treatment
0,146  0,007  Protein 50S ribosomal subunit inhibitor
0,141  0,002  Sodium/glucose cotransporter inhibitor
0,192  0,055  Succinate dehydrogenase inhibitor
0,178  0,042  SULT1A3 substrate
0,162  0,025  Photosensitizer
0,144  0,008  Glycine receptor agonist
0,166  0,031  Antiviral (Poxvirus)
0,149  0,015  UGT2B11 substrate
0,135  0,002  Sodium/glucose cotransporter 2 inhibitor
0,161  0,028  Antiemetic
0,270  0,137  GABA C receptor rho-3 antagonist
0,155  0,030  Antineoplastic (uterine cancer)
0,141  0,016  Interleukin 12 antagonist
0,160  0,035  Growth stimulant
0,257  0,133  Antiprotozoal (Plasmodium)
0,194  0,072  Antiviral (Ebola)
0,154  0,032  GABA C receptor agonist
0,179  0,060  Eye irritation, high
0,131  0,012  Alcohol oxidase inhibitor
0,235  0,117  FMO3 substrate
0,181  0,065  Liver fibrosis treatment
0,235  0,120  Antimycobacterial
0,133  0,018  Ornithine decarboxylase inhibitor
0,162  0,047  Psychosexual dysfunction treatment
0,141  0,027  Uric acid excretion stimulant
0,142  0,028  Antifungal (Pneumocystis)
0,228  0,115  Antineoplastic (multiple myeloma)
0,211  0,099  Aldehyde oxidase inhibitor
0,140  0,029  Creatine kinase inhibitor
0,114  0,004  Caspase 2 inhibitor
0,113  0,004  Adenine nucleotide translocase inhibitor
0,172  0,063  Antiviral (Hepatitis C)
0,110  0,003  Protein 30S ribosomal subunit inhibitor
0,119  0,013  Acyl-CoA dehydrogenase inhibitor
0,221  0,115  5 Hydroxytryptamine uptake stimulant
0,109  0,005  Anesthetic inhalation
0,153  0,048  DNA polymerase I inhibitor
0,123  0,021  Antifungal (Candida)
0,136  0,035  Sulfotransferase substrate
0,119  0,020  Bile acid receptor antagonist
0,140  0,041  Excitatory amino acid transporter EAAC1 inhibitor
0,116  0,019  Interferon agonist
0,104  0,007  Nitric oxide donor
0,158  0,064  Antineoplastic (carcinoma)
0,134  0,040  Aldehyde dehydrogenase substrate
0,103  0,010  Gaucher disease treatment
0,146  0,053  Retinoprotector
0,144  0,052  Antibacterial (Helicobacter pylori)
0,146  0,054  Heat shock protein 70 antagonist
0,138  0,049  Antineoplastic antimetabolite
0,093  0,004  Cytokine production stimulant
0,139  0,051  Vanilloid 1 agonist
0,122  0,037  Anabolic
0,098  0,013  Interferon inducer
0,154  0,069  Antidote
0,208  0,125  Renal disease treatment
0,096  0,013  Antiviral (Parainfluenza)
0,128  0,045  GABA C receptor antagonist
0,104  0,022  Narcotic antagonist
0,193  0,111  Antineoplastic (non-small cell lung cancer)
0,090  0,008  Lipocortins synthesis agonist
0,108  0,027  Glutamate dehydrogenase inhibitor
0,120  0,039  Folate antagonist
0,127  0,047  Nav1.5 sodium channel blocker
0,099  0,019  Biliverdin reductase inhibitor
0,104  0,025  Lipase inhibitor
0,099  0,020  Phosphodiesterase VI inhibitor
0,097  0,018  Aldose reductase inhibitor
0,081  0,003  Sodium/glucose cotransporter 1 inhibitor
0,096  0,019  Antitreponemal
0,096  0,020  Antidote, organophosphates
0,122  0,046  Protease inhibitor
0,090  0,014  Phosphorylase inhibitor
0,146  0,071  Hair growth stimulant
0,079  0,004  Uridine phosphorylase inhibitor
0,090  0,015  SULT2A1 substrate
0,114  0,044  Antihypermotility
0,139  0,070  Neurotrophic factor
0,073  0,004  Guanylate cyclase inhibitor
0,150  0,081  Anticoagulant
0,134  0,065  Toll-Like receptor 2 antagonist
0,092  0,023  Anticholelithogenic
0,134  0,066  Interleukin 4 antagonist
0,082  0,014  Glucosylceramidase inhibitor
0,142  0,075  Antiprotozoal (Coccidial)
0,137  0,071  Contraceptive
0,076  0,011  Adenosine deaminase inhibitor
0,145  0,080  Peroxidase inhibitor
0,076  0,013  Glucose-6-phosphate translocase inhibitor
0,086  0,023  Argininosuccinate synthase inhibitor
0,117  0,054  Antihelmintic (Fasciola)
0,124  0,062  Cholesterol synthesis inhibitor
0,202  0,140  CYP2D6 substrate
0,107  0,046  Lanosterol 14 alpha demethylase inhibitor
0,103  0,043  Arylamine N-Acetyltransferase substrate
0,071  0,011  Heparanase inhibitor
0,090  0,031  Phenylalanine 4-hydroxylase inhibitor
0,104  0,045  Antineoplastic alkaloid
0,070  0,011  Thymidine kinase inhibitor
0,102  0,043  Restless leg syndrome treatment
0,060  0,001  Telomerase stimulant
0,157  0,099  Sedative
0,092  0,034  GABA aminotransferase inhibitor
0,102  0,047  Antiviral (Rhinovirus)
0,069  0,014  Squalene epoxidase inhibitor
0,127  0,072  Antihelmintic (Trematoda)
0,079  0,025  Glutamate (mGluR6) antagonist
0,073  0,019  Carbonic anhydrase XIV inhibitor
0,064  0,010  Microtubule stabilization
0,153  0,100  Lipocortins synthesis antagonist
0,117  0,065  Menstruation disorders treatment
0,080  0,030  Protein kinase C beta inhibitor
0,055  0,005  Ceramide glucosyltransferase inhibitor
0,113  0,063  SULT1A1 substrate
0,076  0,027  Carbonic anhydrase XII inhibitor
0,139  0,090  GABA C receptor rho-2 antagonist
0,056  0,009  Kainate receptor agonist
0,075  0,028  Purinergic P2X1 antagonist
0,093  0,046  Antiviral (Trachoma)
0,048  0,002  Antibiotic Anthracycline-like
0,138  0,093  UGT1A3 substrate
0,074  0,030  Carbonic anhydrase IX inhibitor
0,090  0,046  Antiprotozoal activity enhancer
0,131  0,087  Cyclooxygenase inhibitor
0,190  0,146  Flavin-containing monooxygenase substrate
0,074  0,030  Antihemophilic
0,052  0,009  Cholesterol absorption inhibitor
0,117  0,075  Contraceptive female
0,136  0,096  UGT1A4 substrate
0,070  0,030  Androgen agonist
0,087  0,048  Antiviral (RSV)
0,060  0,021  Antiviral (Herpesvirus 3, Human)
0,042  0,004  Vanilloid 2 agonist
0,043  0,004  GRP78 expression inhibitor
0,052  0,014  Arginase inhibitor
0,104  0,066  UGT2B1 substrate
0,048  0,011  Sodium-dependent vitamin C transporter 2 inhibitor
0,050  0,013  Fumarate hydratase inhibitor
0,077  0,040  Phospholipase D inhibitor
0,126  0,090  Farnesoid X receptor antagonist
0,097  0,061  Interleukin 1 beta converting enzyme inhibitor
0,103  0,067  Mediator release inhibitor
0,054  0,019  Neuraminidase (Influenza A) inhibitor
0,039  0,004  1,3-Beta-glucan synthase inhibitor
0,278  0,243  Ca2+/calmodulin-dependent protein kinase kinase A inhibitor
0,098  0,063  Antifibrinolytic
0,045  0,010  Hypoxanthine phosphoribosyltransferase inhibitor
0,085  0,052  Estrogen-related receptor beta agonist
0,117  0,084  Anesthetic
0,057  0,024  Potassium channel (Inward rectifier) activator
0,058  0,026  Prolyl endopeptidase inhibitor
0,103  0,071  DNA intercalator
0,072  0,039  Exportin-1 inhibitor
0,037  0,005  Toll-Like receptor 4 agonist
0,054  0,023  Potassium channel (ATP-sensitive) activator
0,061  0,031  Ornithine carbamoyltransferase inhibitor
0,037  0,009  Purinergic P2Y15 antagonist
0,076  0,049  Adenosine A3 receptor antagonist
0,095  0,069  GABA C receptor rho-1 antagonist
0,089  0,063  Paget's disease treatment
0,072  0,048  Prokinetic
0,113  0,089  Antihyperlipoproteinemic
0,029  0,005  Ileal bile acid transport inhibitor
0,029  0,006  Isoleucine-tRNA ligase inhibitor
0,037  0,014  Glutamate (mGluR3) agonist
0,031  0,008  Prostaglandin F2 alpha agonist
0,065  0,043  Carbonic anhydrase inhibitor
0,141  0,119  Aldehyde oxidase substrate
0,057  0,036  Sphingosine kinase 2 inhibitor
0,125  0,104  Antidiabetic (type 1)
0,057  0,037  Carbonic anhydrase I inhibitor
0,045  0,026  Toll-Like receptor 2 agonist
0,181  0,162  Transcription factor STAT3 inhibitor
0,034  0,015  Caspase 6 inhibitor
0,126  0,107  Phospholipase A2 inhibitor
0,020  0,002  Purinergic P2Y2 agonist
0,071  0,053  Aminopeptidase I inhibitor
0,180  0,164  Antiviral (West Nile virus)
0,070  0,054  Catalase inhibitor
0,055  0,039  Carbonic anhydrase II inhibitor
0,052  0,036  Aconitate hydratase inhibitor
0,046  0,032  Adenylate cyclase 1 inhibitor
0,037  0,022  Phosphoglycerate kinase inhibitor
0,020  0,007  Purinergic P2Y1 agonist
0,071  0,058  Carbonic anhydrase XIII inhibitor
0,047  0,034  Cholesterol esterase inhibitor
0,023  0,012  Corticosteroid-like
0,089  0,079  Tourette's syndrome treatment
0,024  0,013  Adenosine kinase inhibitor
0,018  0,008  Antibiotic Macrolide-like
0,018  0,008  Purinergic P2 agonist
0,018  0,008  Purinergic receptor agonist
0,091  0,081  Ferrochelatase inhibitor
0,019  0,010  Methylmalonyl-CoA mutase inhibitor
0,068  0,058  Glutamate decarboxylase inhibitor
0,065  0,056  Histidine decarboxylase inhibitor
0,143  0,134  Osteoarthritis treatment
0,076  0,068  Glutathione S-transferase inhibitor
0,029  0,021  RNA-directed RNA polymerase stimulant
0,037  0,029  Glutamate (mGluR8) agonist
0,041  0,033  HIV-1 protease inhibitor
0,131  0,125  Tumour necrosis factor antagonist
0,026  0,020  Thymidine kinase (Herpes simplex virus 1) inhibitor
0,091  0,085  Antiprotozoal (Toxoplasma)
0,053  0,047  Postcoital contraceptive
0,027  0,021  Hedgehog signaling activator
0,098  0,092  Acetylcholine release stimulant
0,013  0,008  Purinergic P2Y agonist
0,055  0,049  Sphingosine kinase inhibitor
0,044  0,040  Estrogen agonist
0,018  0,015  Apical sodium codependent bile acid transporter inhibitor
0,018  0,016  Inosine monophosphate dehydrogenase 1 inhibitor
0,052  0,050  3-Oxoacyl-[acyl-carrier-protein] synthase inhibitor
0,003  0,002  Purinergic P2Y6 agonist
0,024  0,023  Thymidine phosphorylase inhibitor
0,048  0,047  3(or 17)beta-hydroxysteroid dehydrogenase inhibitor
0,144  0,142  Insulin sensitizer
0,053  0,053  Antidote, heavy metal
0,044  0,044  Topoisomerase II beta inhibitor

